Outbreak of mumps in a vaccinated child population: A question of vaccine failure?

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2713-2716

  Vandermeulen, Corinne ^a   Roelants, Mathieu ^a   Vermoere, Marijke ^b   Roseeuw, Katelijn ^b   Goubau, Patrick ^c   Hoppenbrouwers, Karel ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Pupil Guidance Centre Brugge(n)   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Mumps; Outbreak; Vaccination

Indexed keywords

MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

ARTICLE; BELGIUM; CHILD; DRUG DOSE REGIMEN; EPIDEMIC; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MEASLES; MUMPS; POPULATION; PRIORITY JOURNAL; RUBELLA; TREATMENT FAILURE; VACCINATION;

BELGIUM; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; MALE; MASS IMMUNIZATION; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; ODDS RATIO; TREATMENT FAILURE;

EID: 3142538786     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.001     Document Type: Article

References (12)

1. Hersh B.S., Fine P.E.M., Kent K.W., Cochi S.L., Kahn L.H., Zell E.R., et al. Mumps outbreak in a highly vaccinated population. J. Pediatr. 119(2):1991;187-193
2. Briss P.A., Fehrs L.J., Parker R.A., Wright P.F., Sanella E.L., Hutcheson R.H., et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J. Infect. Dis. 169:1994;77-82
3. Cheek J.E., Baron R., Atlas H., Wilson D.L., Crider R.D. Mumps outbreak in a highly vaccinated school population. Arch. Pediatr. Adolesc. Med. 149:1995;774-778
4. Schluter WW, Wharton M. CDC manual on internet. Mumps; 1999. chapter 7, p. 1-6. http://www.cdc.gov/nip/publications/pink/mumps.pdf.
5. Orenstein W.A., Bernier R.H., Dondero T.J., Hinman A.R., Marks J.S., Bart K.J., et al. Field evaluation of vaccine efficacy. Bull. WHO. 63(6):1985;1055-1068
6. Anderson R.M., May R.M. Immunisation and herd immunity. Lancet. 335:1990;641-645
7. Vellinga A., Depoorter A.M., Van Damme P. Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. Acta Pediatric. 91(5):2001;599-603
8. Plotkin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Saunders: Philadelphia; 2004. p. 441-69.
9. Kim-Farley R., Bart S., Stetler H., Orenstein W., Bart K., Sullivan K., et al. Clinical mumps vaccine efficacy. Am. J. Epidemiol. 121(4):1985;593-597
10. Narita M., Matsuzono Y., Takekoshi Y., Yamada S., Itakura O., Kulota M., et al. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin. G. Clin. Diagn. Lab. Immunol. 5(6):1998;799-803
11. Peltola H., Heinonen O.P., Valle M., Paunio M., Virtanen M., Karahka V., et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12 year, two-dose vaccination program. N. Engl. J. Med. 331(21):1994;1397-1402
12. Heath T.C., Burgess M.A., Forrest J.M. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella. CDI. 22(8):1998;157-158